2451 - 2475 of 9140 Results
Title
Year
-
OPENTitle: Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1972End Page: 1978Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28608Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28608Citation Count: 40
- Thalamic Dorsomedial Nucleus Free Water Correlates with Cognitive Decline in Parkinson's Disease2021OPENTitle: Thalamic Dorsomedial Nucleus Free Water Correlates with Cognitive Decline in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 490End Page: 501Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28886Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8940677Citation Count: 22
-
OPENTitle: Cholinergic Nucleus 4 Degeneration and Cognitive Impairment in Isolated Rapid Eye Movement Sleep Behavior DisorderJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 3Start Page: 474End Page: 479Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29306Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29306Citation Count: 21
-
OPENTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 UpdateJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 4Start Page: 427End Page: 439Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-239901Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd239901?id=journal-of-parkinsons-disease%2Fjpd239901Citation Count: 89
-
OPENTitle: GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathologyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 19Start Page: 1944End Page: 1950Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182735e9aBest OA location URL: https://n.neurology.org/content/neurology/79/19/1944.full.pdfCitation Count: 155
- Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)2020RESTRICTEDTitle: Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4418Citation Count: 1
-
OPENTitle: A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal FluidJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 4Start Page: e0153564End Page: e0153564Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0153564Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0153564&type=printableCitation Count: 8
-
OPENTitle: Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP CohortJournal Name: The American Journal of PathologyPublisher: Elsevier BVVol: 184Issue #: 4Start Page: 966End Page: 975Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ajpath.2013.12.007Best OA location URL: http://ajp.amjpathol.org/article/S0002944014000121/pdfCitation Count: 142
-
OPENTitle: Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 3Start Page: 312End Page: 312Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2020.4725Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2773698/jamaneurology_simuni_2020_oi_200091_1614894403.37383.pdfCitation Count: 146
-
OPENTitle: Longitudinal prevalence of neurogenic orthostatic hypotension in the idiopathic Parkinson Progression Marker Initiative (PPMI) cohortJournal Name: Autonomic NeurosciencePublisher: Elsevier BVVol: 253Issue #:Start Page: 103173End Page: 103173Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.autneu.2024.103173Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11128342/pdf/nihms-1990184.pdfCitation Count: 12
- The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson's Disease2018OPENTitle: The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 2Start Page: 171End Page: 176Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.12591Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12591Citation Count: 67
- Dopamine transporter imaging is associated with long‐term outcomes in Parkinson's disease2012RESTRICTEDTitle: Dopamine transporter imaging is associated with long‐term outcomes in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 11Start Page: 1392End Page: 1397Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25157Citation Count: 135
-
OPENTitle: The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorderJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 1Start Page: 88End Page: 98Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27105Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27105Citation Count: 569
-
OPENTitle: Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 4Start Page: 895End Page: 904Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28399Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10123546/pdf/nihms-1876686.pdfCitation Count: 59
-
OPENTitle: Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 140Issue #: 3Start Page: 341End Page: 358Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-020-02181-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-020-02181-3.pdfCitation Count: 119
-
OPENTitle: MDGA2 homozygous loss-of-function variants cause developmental and epileptic encephalopathyJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 113Issue #: 2Start Page: 380End Page: 391Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.ajhg.2025.12.015Best OA location URL: https://doi.org/10.1016/j.ajhg.2025.12.015Citation Count: 1
-
OPENTitle: Longitudinal study investigating the influence of COMT gene polymorphism on cortical thickness changes in Parkinson's disease over four yearsJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 9920End Page: 9920Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-60828-7Best OA location URL: https://doi.org/10.1038/s41598-024-60828-7Citation Count: 1
-
OPENTitle: Mitophagy bridges glucose metabolism, inflammation and neuroprotection in astrocytesJournal Name: AutophagyPublisher: Informa UK LimitedVol: 22Issue #: 5Start Page: 1129End Page: 1131Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1080/15548627.2026.2623987Best OA location URL: https://doi.org/10.1080/15548627.2026.2623987Citation Count: 1
- Data‐driven disease progression model of Parkinson's disease and effect of sex and genetic variants2024OPENTitle: Data‐driven disease progression model of Parkinson's disease and effect of sex and genetic variantsJournal Name: CPT: Pharmacometrics & Systems PharmacologyPublisher: WileyVol: 13Issue #: 4Start Page: 649End Page: 659Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/psp4.13112Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/psp4.13112Citation Count: 11
-
OPENTitle: Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer's dementia in a community autopsy cohortJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 10Start Page: 4377End Page: 4387Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.13357Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10592344/pdf/nihms-1919180.pdfCitation Count: 13
- ePresentations2024OPENTitle: ePresentationsJournal Name: European Journal of NeurologyPublisher: WileyVol: 31Issue #: S1Start Page: e16338End Page: e16338Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ene.16338Best OA location URL: https://doi.org/10.1111/ene.16338Citation Count: 0
-
OPENTitle: Patient-centered development of clinical outcome assessments in early Parkinson disease: key priorities and advancesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 101End Page: 101Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00716-zBest OA location URL: https://doi.org/10.1038/s41531-024-00716-zCitation Count: 12
- Parkinson’s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B2023OPENTitle: Parkinson’s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55BJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 50Start Page: eadj1205End Page: eadj1205Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.adj1205Best OA location URL: https://assets.thermofisher.com/TFS-Assets/LSG/manuals/Lipofectamine_RNAiMAX_Reag_protocol.pdfCitation Count: 34
-
OPENTitle: The vermiform appendix impacts the risk of developing Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 465Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aar5280Best OA location URL: https://hal.science/hal-04247698Citation Count: 276
-
OPENTitle: Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson's diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 87Issue #: 10Start Page: 1112End Page: 1122Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2015-312690Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5154297Citation Count: 37